Drug Shortage Report for FOQUEST

Last updated on 2024-04-30 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-04-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2022-07-04 French Compare
v22 2022-07-22 English Compare
v23 2022-07-22 French Compare
v24 2022-07-29 English Compare
v25 2022-07-29 French Compare
v26 2022-08-04 English Compare
v27 2022-08-04 French Compare
v28 2022-08-29 English Compare
v29 2022-08-29 French Compare
v30 2022-09-09 English Compare
v31 2022-09-09 French Compare
v32 2022-09-16 English Compare
v33 2022-09-16 French Compare
v34 2022-09-22 English Compare
v35 2022-09-22 French Compare
v36 2022-09-30 English Compare
v37 2022-09-30 French Compare
v38 2022-09-30 English Compare
v39 2022-09-30 French Compare
v40 2022-10-07 English Compare

Showing 21 to 40 of 157